4-Methyl-3-[(3-methylbutanoyl)amino]benzoic acid, 95.0%, 5g

Tetra-n-butylammonium dichlorobromide, 97.0%, 1g

Methyl 3-(3-carbamoyl-4-(3-methoxyphenylamino)-8-methylquinolin-6-ylsulfonyl)benzoate, 98%, 500mg

4-(4-Pyridyl)benzaldehyde>98.0%(GC)200mg

Glass syringe Dosys with Luer connection (glass), 100 ml, 1 piece

Centrifuge filter unit Ultrafree-CL, PVDF membrane, sample volume up to 2.0 ml, 0,65 µm, Non-sterile, 25 Piece(s)

5-Iodo-2-methoxythiazole, 98%, 250mg

2-Methyl-3-nitropyridine>98.0%(GC)1g

(3aR,8aS)-2-([2,2'-Bipyridin]-6-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole, 98%, 250mg

(2,2-Dimethyl-2,3-dihydrobenzofuran-5-yl)boronic acid, 95%, 500mg

1-(5-METHYL-3-NITROPYRIDIN-2-YL)ETHAN-1-ONE, 95%, 1g

Ethyl (6-oxopyridazin-1(6H)-yl)acetate, 95.0%, 250mg

1,1,4,4, Tetramethyl-1,4-disila-5-oxacyclopentane, 97%, 5g